Revenue vs Net income
Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.
Margin trend
Gross, operating and net margin. Margins are derived from reported dollars.
Revenue YoY growth
Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).
Income statement
From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $63.7B | $65.6B | $65.5B | $67.2B | $69.7B | $72.5B | $68.5B | $71.7B |
| YoY | — | — | — | — | +9.5% | +10.4% | +4.6% | +6.7% |
| Cost of goods sold | $47.6B | $49.0B | $48.4B | $53.3B | $55.5B | $57.8B | $54.1B | $56.7B |
| YoY | — | — | — | — | +16.7% | +17.9% | +11.8% | +6.4% |
| Gross profit | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Selling, general & administrative | $3.6B | $3.9B | $4.2B | $3.4B | $3.4B | $3.6B | $3.7B | $3.5B |
| YoY | — | — | — | — | -6.4% | -6.6% | -11.7% | +1.1% |
| Operating income | $2.6B | $2.2B | $2.0B | $2.3B | $2.6B | $2.3B | $2.4B | $2.7B |
| YoY | — | — | — | — | +0.1% | +7.9% | +19.6% | +16.0% |
| Pretax income | $1.2B | $2.0B | $1.6B | $2.0B | $2.3B | $1.8B | $2.3B | $2.3B |
| YoY | — | — | — | — | +92.5% | -9.6% | +37.7% | +11.7% |
| Income tax | $367.0M | $473.0M | $239.0M | $389.0M | $322.0M | $543.0M | $409.0M | $382.0M |
| YoY | — | — | — | — | -12.3% | +14.8% | +71.1% | -1.8% |
| Net income | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| EPS — basic | $2.65 | — | $4.88 | $5.76 | $7.02 | — | $6.30 | $6.31 |
| YoY | — | — | — | — | +164.9% | — | +29.1% | +9.5% |
| EPS — diluted | $2.63 | — | $4.85 | $5.71 | $6.98 | — | $6.26 | $6.29 |
| YoY | — | — | — | — | +165.4% | — | +29.1% | +10.2% |
| Weighted shares — basic | — | — | — | — | — | — | — | — |
| Weighted shares — diluted | 281.4M | — | 273.0M | 268.2M | 267.5M | — | 264.0M | 264.0M |
Balance sheet
Point-in-time values at each quarter (or fiscal year) end.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.9B | $7.5B | $8.3B | $4.3B | $6.0B | $7.7B | $7.0B | $6.3B |
| YoY | — | — | — | — | +2.3% | +1.7% | -15.5% | +45.5% |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Accounts receivable | $27.8B | $24.2B | $26.9B | $31.1B | $31.7B | $28.8B | $26.6B | $30.8B |
| YoY | — | — | — | — | +13.9% | +18.7% | -1.2% | -1.1% |
| Inventory | $5.1B | $6.7B | $5.2B | $6.0B | $5.6B | $7.3B | $5.8B | $5.8B |
| YoY | — | — | — | — | +10.8% | +9.7% | +12.7% | -2.0% |
| Total current assets | $49.2B | $48.9B | $43.6B | $44.7B | $46.7B | $47.8B | $43.0B | $47.0B |
| YoY | — | — | — | — | -5.1% | -2.2% | -1.2% | +5.1% |
| Total assets | $157.6B | $155.9B | $150.7B | $151.7B | $157.9B | $157.9B | $153.3B | $157.1B |
| YoY | — | — | — | — | +0.2% | +1.3% | +1.7% | +3.6% |
| Total current liabilities | $57.1B | $58.0B | $55.7B | $56.8B | $56.5B | $56.3B | $52.6B | $55.6B |
| YoY | — | — | — | — | -1.1% | -2.8% | -5.6% | -2.1% |
| Total liabilities | $115.3B | $114.6B | $110.2B | $111.2B | $115.9B | $116.0B | $110.8B | $114.2B |
| YoY | — | — | — | — | +0.5% | +1.2% | +0.5% | +2.7% |
| Total equity | $42.1B | $41.0B | $40.2B | $40.2B | $41.8B | $41.7B | $42.2B | $42.6B |
| YoY | — | — | — | — | -0.7% | +1.7% | +4.9% | +6.0% |
| Shares outstanding | — | 273.8M | — | — | — | 263.5M | — | — |
| YoY | — | — | — | — | — | -3.8% | — | — |
Cash flow
Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $46.0M | $5.2B | $1.9B | $-1.9B | $3.4B | $6.1B | $1.1B | $-421.0M |
| YoY | — | — | — | — | +7330.4% | +18.0% | -41.1% | +77.7% |
| Capital expenditures | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Share repurchases | $0 | $2.0B | $1.5B | $1.1B | $0 | $1.0B | $0 | $280.0M |
| YoY | — | — | — | — | — | -50.5% | -100.0% | -74.8% |
Margins & ratios
Derived from the reported dollars above — no separate source.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 4.0% | 3.3% | 3.0% | 3.4% | 3.7% | 3.2% | 3.4% | 3.7% |
| Net margin | — | — | — | — | — | — | — | — |
| Free cash flow margin | — | — | — | — | — | — | — | — |
| Effective tax rate | 30.8% | 23.5% | 14.5% | 19.2% | 14.0% | 29.9% | 18.0% | 16.9% |
| Current ratio | 0.86x | 0.84x | 0.78x | 0.79x | 0.83x | 0.85x | 0.82x | 0.85x |
| Total liabilities / equity | 2.74x | 2.79x | 2.74x | 2.77x | 2.77x | 2.78x | 2.63x | 2.68x |
Peer comparison — latest full year
Same sector (Health Care), sorted by revenue. All figures from the same EDGAR XBRL snapshot.
| Ticker | Revenue | Revenue YoY | Gross margin | Operating margin | Net margin | FCF margin |
|---|---|---|---|---|---|---|
| CI FY25 · this stock | $274.9B | +11.2% | — | 3.3% | — | — |
| UNH FY25 | $447.6B | +11.8% | — | 4.2% | 2.7% | 3.6% |
| CVS FY25 | $402.1B | +7.8% | — | 1.2% | 0.4% | 1.9% |
| ELV FY25 | $199.1B | +12.5% | — | 3.6% | 2.8% | 1.6% |
| JNJ FY25 | $94.2B | +6.0% | 67.9% | — | 28.5% | 20.9% |
| LLY FY25 | $65.2B | +44.7% | — | — | 31.7% | — |
| MRK FY25 | $65.0B | +1.3% | — | — | 28.1% | 19.0% |
| ABBV FY25 | $61.2B | +8.6% | — | 24.6% | 6.9% | 29.1% |
| BMY FY25 | $48.2B | -0.2% | — | — | 14.6% | 26.7% |
| TMO FY25 | $44.6B | +3.9% | — | 17.4% | 15.0% | 14.1% |
| ABT FY25 | $44.3B | +5.7% | — | 18.2% | 14.7% | 16.7% |
Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.